Stocks › GLUE
Monte Rosa Therapeutics GLUE
US equityMarket cap rank #3349
$8.64 −$0.27 (-3.03%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $8.64 0.00%
Open$8.73
Prev close$8.91
Day range$8.48 – $9.04
Volume2.52M
Market cap$738.29M
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts8
Average target$25.14+191.0% vs. price
- Buy 100%
Low $15.00Now $8.64Avg $25.14High $37.00
Recent rating changes
The last 20 actions on file set price targets from $15.00 to $37.00, averaging $27.41.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 10 Nov 2026 | Piper Sandler | BUY | $37.00 |
| 6 Nov 2026 | Wells Fargo | BUY | $25.00 |
| 6 Nov 2026 | Wedbush | BUY | $27.00 |
| 6 Nov 2026 | H.C. Wainwright | BUY | $25.00 |
| 5 Nov 2026 | Jefferies | BUY | $15.00 |
| 5 Nov 2026 | Guggenheim | BUY | $28.00 |
| 12 Oct 2026 | UBS | BUY | $19.00 |
| 5 Oct 2026 | H.C. Wainwright | BUY | $25.00 |
| 2 Oct 2026 | LifeSci Capital | BUY | – |
| 2 Oct 2026 | Piper Sandler | BUY | $37.00 |
| 2 Oct 2026 | Wedbush | BUY | $27.00 |
| 1 Oct 2026 | Guggenheim | BUY | $28.00 |
| 1 Oct 2026 | H.C. Wainwright | BUY | $25.00 |
| 8 Sep 2026 | LifeSci Capital | BUY | – |
| 8 Sep 2026 | Guggenheim | BUY | $28.00 |
| 24 Aug 2026 | Guggenheim | BUY | $28.00 |
| 12 Aug 2026 | Guggenheim | BUY | $28.00 |
| 10 Aug 2026 | J.P. Morgan | BUY | $27.00 |
| 7 Aug 2026 | Piper Sandler | BUY | $37.00 |
| 6 Aug 2026 | LifeSci Capital | BUY | – |
No comments yet — be the first to weigh in on GLUE.
Sign in to join the discussion.